Prokinecitine in Acute Myocardial Infarction

Terminated

• Conditions: ST Elevatation Myocardial Infarction (STEMI)

• Registration Number: NCT02021487
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The study aims to investigate the presence of a substance in the blood called prokinecitine, which is released by the heart when a heart attack occurs. Several venous blood samples at the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the concentration of this substance in the blood. The usefulness of this new blood marker is going to be determsined to seek if it would be of help to better diagnose or estimate the gravity of heart infarction after a heart attack.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11
• Study First Submitted: 2013-12-19
• Study First Submitted QC: 2013-12-19
• Study First Posted: 2013-12-27
• Primary Completion: 2019-02
• Study Completion: 2019-02
• Status Verified: 2019-08
• Last Update Submitted: 2019-08-19
• Last Update Posted: 2019-08-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 172

Inclusion Criteria

• Patients with acute St elevation myocardial infarction of less than 6 hours
• Age>18 y/o

Exclusion Criteria

• Previous myocardial infarction
• LBB, RBB
• Renal Insuffiency MDRD<30 mL/min
• Patient with Pace-Maker or ICD.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infarct size by MRI necrotic myocardial mass	7 days	Infarct size by MRI necrotic myocardial mass

Trial Locations

Locations (1)

University Hospital; 🇫🇷 Strasbourg, France